grant
savePHUSIS THERAPEUTICS, INC. — Clinical evaluation of a novel AKT/PDK1 inhibitor, PHT-427, for the treatment...
September 15, 2025updated 2mo ago
community read0 votes
CA grant. $2,085,765. PI: GARTH POWIS
view source ↗CA grant. $2,085,765. PI: GARTH POWIS
view source ↗
comments(0)
5-min edit window · permanent after that